The Russian pharmaceutical company “Nanolek” was founded in 2011. It specializes in the production of import-substituting medicines for the prevention and treatment of socially significant diseases.
In 2020, the company was recognized as a backbone enterprise of the Russian economy. In 2021, “Nanolek” was included in RBC's rating — “50 Fastest Growing Companies in Russia”.
“Nanolek” has accumulated a unique experience in technology transfer:
more than 10 innovative drugs have been localized at the plant in the Kirov region in partnership with big pharma companies — world industryleaders.
20% of which are engaged solely in qualitycontrol
in the portfolio. 20 more drugs are underdevelopment
have been invested in the company since2011
taxes paid to in the Kirov region over the past 3years
NANOLEK IS A MEMBER OF ASSOCIATIONS
NANOLEK IS THE LEADER OF RATINGS
Protect people's lives and health by producing the world's best technologies, made available to everyone
From the localization of the drugs of global pharmaceutical companies, to the biotech production of a full cycle and the development of innovative medicines “from scratch”
CEO, Chairman of the Board
First Deputy General Director, Director of the Vaccines Division, Member of the Management Board
Deputy General Director for Strategic Development, Director of the Specialized Products Division, Member of the Management Board
Deputy General Director for Investments and Digital Technologies, Member of the Management Board
Deputy General Director for Human Resources and Administrative Affairs, Member of the Management Board
Director of the Biomedical Complex, Deputy General Director for Operations and Partner Relations, Member of the Management Board
Deputy General Director for Development and Research, Member of the Management Board
Deputy General Director for Legal Affairs and Work with Public Authorities, Member of the Management Board
Deputy General Director for Commercial Activities, Member of the Management Board
Director of Quality Management Department / Authorized Person
Director of Information Technology Department
Director of the Department for the Development of Economic Territories
Our rule, without exception: All “Nanolek” partners are leaders in their field with impeccable reputations.
*GMP (Good Manufacturing Practice) —rules that establish requirements for the organization of production and quality control of drugs for medical and veterinary use.
**ISO 9001 — this standard is based on a number of quality management principles, such as strong customer orientation, management involvement and motivation, process approach and continuous improvement. The application of ISO 9001 helps to ensure that customers consistently receive high-quality products and services.
AGREEMENT ON OBTAINING INFORMATION ON PRESCRIPTION DRUGS
1. In this section of the site, Nanolek LLC provides information on prescription drugs, methods of application, composition, properties, and possible contraindications. This information is intended for medical and healthcare professionals (employees with specialized secondary or higher medical education).
2. If you do not work in medicine or healthcare and accept this agreement in breach of these terms, Nanolek LLC bears no liability for the consequences that might result from you using the information received from this site. You alone shall be responsible for using the information on prescription drugs you find on the pages of this site, since use of these drugs is permissible only after consultation with a doctor.
3. None of the information about prescription drugs provided by Nanolek LLC is intended to be a guide or recommendation for self-treatment, but rather is intended for informational purposes only. In the event of independent administration of the prescription drugs without a medical prescription or prior consultation with a medical professional, Nanolek LLC denies all responsibility for any harm that may be caused to your health or the health of third parties.